Emmanuel Dellanegra

Centre Hospitalier de Saint-Brieuc

Papers

1

Total Citations

2

H-Index

1

About

Emmanuel Dellanegra is a leading urological surgeon and researcher whose work focuses on advancing surgical treatments for benign prostatic hyperplasia (BPH), particularly in cases of extremely large prostate volumes. His major contributions lie in comparing and refining minimally invasive techniques for prostates exceeding 150 cm³, a challenging patient population where traditional open surgery carries significant morbidity. In his highly cited 2025 study, Dellanegra systematically evaluated outcomes between endoscopic enucleation of the prostate (EEP) and robotic-assisted simple prostatectomy (RASP), providing critical evidence to guide surgical decision-making for these complex cases. His research addresses a key clinical gap, as men with giant prostates often face limited options and higher complication rates. With over 2 citations already, this work is shaping contemporary urological practice by demonstrating that both EEP and RASP can be effective, though each offers distinct advantages in recovery time, blood loss, and functional outcomes. Dellanegra’s contributions are particularly valuable for surgeons and trainees seeking evidence-based approaches to managing large-volume BPH, and his ongoing work continues to refine the balance between efficacy and safety in prostate surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Benign prostate hyperplasia over 150 cm3: Should we perform an endoscopic enucleation of the prostate or robotic-assisted simple prostatectomy?
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Centre Hospitalier de Saint-Brieuc

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago